BP001629-C386: Recombinant Human Biglycan (BGN) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001638-C579: Recombinant Human CD44 Antigen (CD44) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001663-C374: Recombinant Human Matrix Metalloproteinase-1 (MMP-1) Enzyme
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001690-C433: Recombinant Human Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Enzyme
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001701-C800: Recombinant Human Serpin H1 Protein
Source: HEK 293-derived.
Purity: > 95% by reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP000038-PRO-582: Recombinant Human Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein
Source: E. coli-derived.
Purity: > 95.0% by RP-HPLC and SDS-PAGE.BP000125-CYT-422: Recombinant Human Tumor Necrosis Factor Receptor (TNFR)
Source: CHO-derived.
A dimeric, glycosylated, polypeptide chain consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component of TNFR contains the CH2 domain, the CH3 domain and hinge region, but not the CH1 domain of IgG1.
Potency is determined by its ability to neutralize TNF-alpha mediated growth inhibition of A375 cells, corresponding to a Specific Activity of 17,000,000 IU/mg.
Purity > 98%, by SDS-PAGE and RP-HPLC.BP000131-CYT-253: Recombinant Human Interleukin-1 alpha (IL-1α) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of murine D10S cells is < 0.001 ug/ml, corresponding to a Specific Activity of 1,000 MIU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000131-CYT-381: Recombinant Rat Interleukin-1 alpha (IL-1α) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependant stimulation of murine D10S cells is < 0.005 ug/ml, corresponding to a Specific Activity of 200,000,000 IU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000132-CYT-094: Recombinant Human Interleukin-1 Beta (IL-1β) Protein, HEK
Source: HEK-derived.
The specific activity was determined by the dose-dependent stimulation of the proliferation of mouse D10S cells and is typically 0.02-0.08 ug/ml.
Purity: > 95% as obsereved by SDS-PAGE.
Reconstitution: It is recommended to reconstitute the lyophilized IL-1 beta in sterile water not less than 100 ?/ml, which can then be further diluted to other aqueous solutions.